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Introduction 
Research dealing on butyrogenic bacteria, i.e. capable to produce butyric acid, has gained 
considerable attention in recent years, since butyric acid exerts an extensive  influence on host 
physiology and gut homeostasis in humans by preventing several intestinal metabolic syndromes 
and their consequential severe degenerations, first of all the colorectal cancer (CRC). In this frame 
it is noteworthy that CRC-associated microbiota is modified by probiotic administration, which may 
represent a relative cheap intervention, capable to enrich the abundance of butyrogenic bacteria in 
the mucosal layer (Hibberd et al., 2017). This Short Chain Fatty Acid (SCFA) is the end-product of 
the intestinal microbial fermentation of undigested dietary fibres, which is mainly ascribed to 
members of Firmicutes, such as Lachnospiraceae, Ruminococcaceae and Clostridium spp. Potential 
butyrogenic capability of  Human Intestinal Microbiome (HIM) is currently inferred by amplicon-
based sequencing and metagenomics. These approaches target specific key genes of butanoate 
pathway that encode for the final enzymatic conversion of butyril-CoA to butyric acid via 
transferases and butyrate kinase (Vital et al., 2014). As for all Lactobacillus sp. that transiently 
colonize the gut microbiota, Lactobacillus (L.) plantarum is considered both an indirect and direct 
butyrogenic species, which may certainly acts by favouring butyric acid production of other bacteria 
or directly producing this SCFA in a strain-dependent manner and in response to specific nutrient 
requirements. In accordance with the fermentation of fibres occurring in the large intestine, 
production of butyric acid in L. plantarum seems triggered by fibres like fructooligosaccharides 
(FOS) and inulin (Esquivel-Elizondo et al., 2017). Although the L. plantarum genome and its 
metabolic pathways are being reconstructed and studied from many years, so far no specific 
metabolic route has been ascribed to the production of butyric acid. 
Therefore, the present study was aimed to unravel the butyrogenic pathway of L. plantarum and its 
triggering environmental factors, as well as the extend by which this metabolic feature may 
determine the anti-cancer activity of this species.         
 
Material and methods 
The putative probiotic strains Lactobacillus plantarum O2T60C, S11T3E and S2T10D (Botta et al., 
2014) were chosen, in relation to their different strains-associated butyrogenic capability in  
substrates not enriched with fibres (Botta et al., 2015; Pessione et al., 2015).  
Their anti-proliferative activity were assessed on HT-29 and Caco-2 cells,  by means of  SRB assay, 
MTT assay and cells counting. Subsequently, to the define whether the growth inhibitory activities 
were related to a modification of aberrant cells cycle or due to the apoptotic cascade activation, we 
carried out a targeted  transcriptomic investigation by using RT-qPCR. The observed transcriptional 
response of the cells to the bacterial treatments were thus confirmed with flow cytometric analysis 
and western blot assay. The organic acid profiles of these strains in the cells culture medium, 
DMEM, were in parallel analyzed by HPLC-UV-RI.  
Moreover, the whole genomes of the three strains were sequenced, de novo assembled and 
annotated to allow a comparative and functional genomics investigation between the butyrogenic 
and non-butyrogenic strains. The genomics comparison was performed up to the level of single 
nucleotide polymorphisms (SNPs) analysis and consequent prediction of protein damaged 
functionality. 
 
Results  
Overall, the strains significantly inhibited the growth of HT-29 colon cancer cells and their 
antiproliferative activities were strongly correlated to the type and amounts of extracellular 
metabolites released in the culture media: a high-glutamine supplemented DMEM. Notably, the 
supernatants of L. plantarum O2T60C poorly inhibited the growth of cancer cells, likely due to its 
inability to produce butyric acid. On the other hand, the butyrate-containing supernatants of 
S2T10D induced a significant pH-independent growth inhibition of cancer cells, which was 
accompanied by a modulation of cyclin D1, and a subsequent cell cycle arrest (Figure 1).  
 
Figure 1. Results of co-incubation treatments of HT-29 cells (from human CRC) with CFSn of S2T10D and O2T60C. 
Cyclin D1 and B1 protein levels(A), cyclin D1 gene expression levels after 12 hours of incubation (B). 
 
Analyzing the genomes  of the three strains we attributed, for the first time the production of butyric 
acid in L. plantarum species, to the complementary activities of the type two fatty acid synthase 
(FASII) and a medium-chain thioesterase (Figure 2). Interestingly, we did not observe differences at 
genomic, structural and SNPs levels in FASII pathway of butyrate-producing strains compared to 
strain O2T60C, in which however we predicted several deleterious mutations for genes responsible 
of glutamine/glutamate metabolism. This in silico observations well correlated with the metabolic 
stress suffered by O2T60 in high-glutamine supplemented DMEM, in which the strain was 
incapable of producing butyrate. On the other hand the glutamine triggered butyric acid production 
in S2T1D and S11T3E. 
  
 
Figure 2. Proposed butyrogenic pathway in  L. plantarum species.  The medium -chain thioesterase (TE) acts by 
truncating the fatty acid synthase of type II (FASII) after the first elongation cycle . 
 
 
Discussion 
Our results suggest a cell cycle modulation and consequently a growth arrest  of CRC cells co-
cultured with the supernatants of butyrogenic strains of L. plantarum, which act mainly on the 
expressed level of cyclin D1 and B1. However, the mechanism underlying these anticancer 
activities seems to be multifaceted and generally correlated to the bacterial growth. Nevertheless, a 
clear involvement of butyric acid in the anti-proliferation activity of  L. plantarum towards cancer 
cells was here proposed for the first time. The comparative and functional genomics assessment of 
butyrogenic and non-butyrogenic strains of L. plantarum allowed us to ascribe this important 
metabolic activity to the FASII pathway, and identified the glutamine as a powerful triggering 
nutritional component different from fibres. 
Regardless from the limited impact of a butyrogenic activity of L. plantarum in DMEM, the 
outcomes of this study may lead to reconsider the role played by this species and other commensal 
lactobacilli in the intestinal butyrogenesis and prevention of colorectal cancer. 
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